3,5-Diiodo-l-thyronine ameliorates diabetic nephropathy in streptozotocin-induced diabetic rats

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 5, 2013, Pages 674-684

  Shang, Guoguo ^a   Gao, Pan ^a   Zhao, Zhonghua ^a   Chen, Qi ^a   Jiang, Tao ^a   Zhang, Nong ^a   Li, Hui ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

3, 5 Diiodothyronine; Diabetic nephropathy; JNK; Mesangial cells; NF B; SIRT1

Indexed keywords

3,5 DIIODO THYRONINE; ALBUMIN; COLLAGEN TYPE 4; CREATININE; FIBRONECTIN; GLUCOSE; PROTEIN; SIRTINOL; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE; THYRONINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CREATININE URINE LEVEL; DIABETIC NEPHROPATHY; DISEASE COURSE; DOWN REGULATION; EXTRACELLULAR MATRIX; GLUCOSE BLOOD LEVEL; KIDNEY INJURY; KIDNEY MASS; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; STREPTOZOCIN DIABETES; UPREGULATION; URINARY EXCRETION;

ACETYLATION; ANIMALS; BLOTTING, WESTERN; CELL LINE; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DIIODOTHYRONINES; FIBRONECTINS; GENE EXPRESSION; GLUCOSE; IMMUNOHISTOCHEMISTRY; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KIDNEY; MALE; MESANGIAL CELLS; NF-KAPPA B; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIRTUIN 1; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84874572270     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.01.023     Document Type: Article

References (33)

1. Ravera M., Re M., Weiss U., Deferrari L., Deferrari G. Emerging therapeutic strategies in diabetic nephropathy. J. Nephrol. 2007, 20(Suppl. 12):S23-S32.
2. Moreno M., de Lange P., Lombardi A., Silvestri E., Lanni A., Goglia F. Metabolic effects of thyroid hormone derivatives. Thyroid 2008, 18:239-253.
3. Lanni A., Moreno M., Lombardi A., de Lange P., Silvestri E., Ragni M., Farina P., Baccari G.C., Fallahi P., Antonelli A., Goglia F. 3,5-diiodo-l-thyronine powerfully reduces adiposity in rats by increasing the burning of fats. FASEB J. 2005, 19:1552-1554.
4. Mariani L.H., Berns J.S. The renal manifestations of thyroid disease. J. Am. Soc. Nephrol. 2012, 23:22-26.
5. Lin Y., Sun Z. Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes. J. Endocrinol. 2011, 209:185-191.
6. Thallas-Bonke V., Thorpe S.R., Coughlan M.T., Fukami K., Yap F.Y., Sourris K.C., Penfold S.A., Bach L.A., Cooper M.E., Forbes J.M. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway. Diabetes 2008, 57:460-469.
7. Lanni A., Moreno M., Cioffi M., Goglia F. Effect of 3,3'-diiodothyronine and 3,5-diiodothyronine on rat liver oxidative capacity. Mol. Cell. Endocrinol. 1992, 86:143-148.
8. Kume S., Thomas M.C., Koya D. Nutrient sensing, autophagy, and diabetic nephropathy. Diabetes 2012, 61:23-29.
9. Lan H.Y. Transforming growth factor-β/Smad signalling in diabetic nephropathy. Clin. Exp. Pharmacol. Physiol. 2012, 39:731-738.
10. Huang W., Shang W.L., Wang H.D., Wu W.W., Hou S.X. Sirt1 overexpression protects murine osteoblasts against TNF-α-induced injury in vitro by suppressing the NF-κB signaling pathway. Acta Pharmacol. Sin. 2012, 33:668-674.
11. Gao Z., Zhang J., Kheterpal I., Kennedy N., Davis R.J., Ye J. Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity. J. Biol. Chem. 2011, 286:22227-22234.
12. Reismann P., Somogyi A. Diabetes and thyroid disorders. Orv. Hetil. 2011, 152:516-519.
13. Hofer-Inteeworn N., Panciera D.L., Monroe W.E., Saker K.E., Davies R.H., Refsal K.R., Kemnitz J.W. Effect of hypothyroidism on insulin sensitivity and glucose tolerance in dogs. Am. J. Vet. Res. 2012, 73:529-538.
14. Goulart-Silva F., Serrano-Nascimento C., Nunes M.T. Hypothyroidism decreases proinsulin gene expression and the attachment of its mRNA and eEF1A protein to the actin cytoskeleton of INS-1E cells. Braz. J. Med. Biol. Res. 2011, 44:1060-1067.
15. Kowalska I., Borawski J., Nikołajuk A., Budlewski T., Otziomek E., Górska M., Straczkowski M. Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy. Endocrine 2011, 40:95-101.
16. Verga Falzacappa C., Mangialardo C., Madaro L., Ranieri D., Lupoi L., Stigliano A., Torrisi M.R., Bouchè M., Toscano V., Misiti S. Thyroid hormone T3 counteracts STZ induced diabetes in mouse. PLoS One 2011, 6:e19839.
17. Kalofoutis C., Mourouzis I., Galanopoulos G., Dimopoulos A., Perimenis P., Spanou D., Cokkinos D.V., Singh J., Pantos C. Thyroid hormone can favorably remodel the diabetic myocardium after acute myocardial infarction. Mol. Cell. Biochem. 2010, 345:161-169.
18. Cioffi F., Lanni A., Goglia F. Thyroid hormones, mitochondrial bioenergetics and lipid handling. Curr. Opin. Endocrinol. Diabetes Obes. 2010, 17:402-407.
19. De Lange P., Cioffi F., Senese R., Moreno M., Lombardi A., Silvestri E., De Matteis R., Lionetti L., Mollica M.P., Goglia F., Lanni A. Nonthyrotoxic prevention of diet-induced insulin resistance by 3,5-diiodo-l-thyronine in rats. Diabetes 2011, 60:2730-2739.
20. Moreno M., Silvestri E., De Matteis R., de Lange P., Lombardi A., Glinni D., Senese R., Cioffi F., Salzano A.M., Scaloni A., Lanni A., Goglia F. 3,5-Diiodo-l-thyronine prevents high-fat-diet-induced insulin resistance in rat skeletal muscle through metabolic and structural adaptations. FASEB J. 2011, 25:3312-3324.
21. Moreno M., Lombardi A., Lombardi P., Goglia F., Lanni A. Effect of 3,5-diiodo-l-thyronine on thyroid stimulating hormone and growth hormone serum levels in hypothyroid rats. Life Sci. 1998, 62:2369-2377.
22. Liu K., Paterson A.J., Konrad R.J., Parlow A.F., Jimi S., Roh M., Chin E., Kudlow J.E. Streptozotocin, an O-GlcNAcase inhibitor, blunts insulin and growth hormone secretion. Mol. Cell. Endocrinol. 2002, 194:135-146.
23. Boparai R.K., Arum O., Khardori R., Bartke A. Glucose homeostasis and insulin sensitivity in growth hormone-transgenic mice: a cross-sectional analysis. Biol. Chem. 2010, 391:1149-1155.
24. Kim Y.D., Li T., Ahn S.W., Kim D.K., Lee J.M., Hwang S.L., Kim Y.H., Lee C.H., Lee I.K., Chiang J.Y., Choi H.S. Orphan nuclear receptor small heterodimer partner negatively regulates growth hormone-mediated induction of hepatic gluconeogenesis through inhibition of signal transducer and activator of transcription 5 (STAT5) transactivation. J. Biol. Chem. 2012, 287:37098-37108.
25. Ma X., Lin Y., Lin L., Qin G., Pereira F.A., Haymond M.W., Butte N.F., Sun Y. Ablation of ghrelin receptor in leptin-deficient ob/ob mice has paradoxical effects on glucose homeostasis when compared with ablation of ghrelin in ob/ob mice. Am. J. Physiol. Endocrinol. Metab. 2012, 303:E422-E431.
26. Gargalionis A.N., Piperi C., Adamopoulos C., Papavassiliou A.G. Histone modifications as a pathogenic mechanism of colorectal tumorigenesis. Int. J. Biochem. Cell Biol. 2012, 44:1276-1289.
27. Ghizzoni M., Haisma H.J., Maarsingh H., Dekker F.J. Histone acetyltransferases are crucial regulators in NF-κB mediated inflammation. Drug Discov. Today 2011, 16:504-511.
28. Kitada M., Takeda A., Nagai T., Ito H., Kanasaki K., Koya D. Dietary restriction ameliorates diabetic nephropathy through anti-inflammatory effects and regulation of the autophagy via restoration of Sirt1 in diabetic Wistar fatty (fa/fa) rats: a model of type 2 diabetes. Exp. Diabetes Res. 2011, 2011:908185.
29. Li C., Cai F., Yang Y., Zhao X., Wang C., Li J., Jia Y., Tang J., Liu Q. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: involvement of SIRT1 and TGF-β1 pathway. Eur. J. Pharmacol. 2010, 649:382-389.
30. Chuang P.Y., Dai Y., Liu R., He H., Kretzler M., Jim B., Cohen C.D., He J.C. Alteration of forkhead box O (foxo4) acetylation mediates apoptosis of podocytes in diabetes mellitus. PLoS One 2011, 6:e23566.
31. Ebenezer P.J., Mariappan N., Elks C.M., Haque M., Francis J. Diet-induced renal changes in Zucker rats are ameliorated by the superoxide dismutase mimetic TEMPOL. Obesity (Silver Spring) 2009, 17:1994-2002.
32. Jung Y.J., Lee J.E., Lee A.S., Kang K.P., Lee S., Park S.K., Lee S.Y., Han M.K., Kim D.H., Kim W. SIRT1 overexpression decreases cisplatin-induced acetylation of NF-κB p65 subunit and cytotoxicity in renal proximal tubule cells. Biochem. Biophys. Res. Commun. 2012, 419:206-210.
33. Ma F.Y., Sachchithananthan M., Flanc R.S., Nikolic-Paterson D.J. Mitogen activated protein kinases in renal fibrosis. Front. Biosci. (Schol. Ed.) 2009, 1:171-187.